NovoCure Ltd - Common Stock (NVCR) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2015 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
NVCR on Nasdaq
Shares outstanding
111,111,111
Price per share
$12.93
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
91,721,730
Total reported value
$1,185,106,072
% of total 13F portfolios
0%
Share change
-3,192,015
Value change
-$66,176,658
Number of holders
242
Price from insider filings
$12.93
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NovoCure Ltd - Common Stock (NVCR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 8.6% +40% $124,611,746 +$35,408,164 9,644,872 +40% Soleus Capital Master Fund, L.P. 30 Sep 2025
BlackRock, Inc. 8.3% $168,501,151 9,083,620 BlackRock, Inc. 31 Mar 2025
Capital World Investors 1.8% -65% $25,840,000 -$56,626,396 2,000,000 -69% Capital World Investors 30 Sep 2025

As of 30 Sep 2025, 242 institutional investors reported holding 91,721,730 shares of NovoCure Ltd - Common Stock (NVCR). This represents 83% of the company’s total 111,111,111 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NovoCure Ltd - Common Stock (NVCR) together control 69% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 15% 16,769,878 +0.28% 0.01% $216,666,824
BlackRock, Inc. 13% 13,947,558 -1.2% 0% $180,202,455
VANGUARD GROUP INC 9.4% 10,455,841 -2.8% 0% $135,089,466
Soleus Capital Management, L.P. 8.7% 9,644,872 +40% 6.7% $124,611,746
STATE STREET CORP 2.3% 2,610,688 -2.5% 0% $33,730,089
GEODE CAPITAL MANAGEMENT, LLC 2.2% 2,474,988 +1.2% 0% $31,981,566
Capital World Investors 1.8% 2,000,000 -69% 0% $25,840,000
Nuveen, LLC 1.5% 1,707,842 +66% 0.01% $22,065,319
Quantinno Capital Management LP 1.4% 1,522,168 +11% 0.05% $19,666,411
MILLENNIUM MANAGEMENT LLC 1.2% 1,335,490 +106% 0.01% $17,254,531
Palo Alto Investors LP 1.1% 1,256,159 +31% 3% $16,229,574
AMERICAN CENTURY COMPANIES INC 1.1% 1,218,807 +18% 0.01% $15,746,987
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.1% 1,195,624 -13% 0% $15,447,463
BAILLIE GIFFORD & CO 1% 1,124,031 -0.41% 0.01% $14,522,480
RENAISSANCE TECHNOLOGIES LLC 0.97% 1,072,854 -17% 0.02% $13,861,274
MARSHALL WACE, LLP 0.93% 1,034,978 -27% 0.01% $13,371,916
C WorldWide Group Holding A/S 0.87% 971,784 +56% 0.19% $12,555,000
T. Rowe Price Investment Management, Inc. 0.85% 945,426 +32% 0.01% $12,215,000
MORGAN STANLEY 0.82% 916,154 +25% 0% $11,836,713
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.82% 910,149 -0.02% 0% $11,759,125
GOLDMAN SACHS GROUP INC 0.81% 904,506 +21% 0% $11,686,218
NORTHERN TRUST CORP 0.81% 897,120 -21% 0% $11,590,790
SILVERCREST ASSET MANAGEMENT GROUP LLC 0.64% 706,075 +31% 0.06% $9,122,489
ALGERT GLOBAL LLC 0.61% 682,858 +372% 0.15% $8,823,000
VOLORIDGE INVESTMENT MANAGEMENT, LLC 0.57% 631,544 -15% 0.03% $8,159,548

Institutional Holders of NovoCure Ltd - Common Stock (NVCR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 490,794 $6,381,657 +$3,683,565 $12.93 21
2025 Q3 91,721,730 $1,185,106,072 -$66,176,658 $12.92 242
2025 Q2 94,465,807 $1,681,500,579 -$12,863,892 $17.80 238
2025 Q1 95,188,552 $1,696,317,176 +$20,032,618 $17.82 224
2024 Q4 91,572,450 $2,728,943,845 -$6,464,722 $29.80 236
2024 Q3 92,870,663 $1,451,669,038 -$11,191,370 $15.63 220
2024 Q2 92,908,941 $1,591,540,722 +$79,622,550 $17.13 229
2024 Q1 89,139,144 $1,393,246,216 -$17,794,761 $15.63 231
2023 Q4 90,513,054 $1,351,320,799 -$31,137,056 $14.93 213
2023 Q3 92,292,343 $1,490,614,876 -$68,391,278 $16.15 219
2023 Q2 90,419,824 $3,752,040,945 +$42,388,515 $41.50 255
2023 Q1 89,476,517 $5,380,865,921 +$285,351,944 $60.14 291
2022 Q4 84,791,322 $6,218,802,349 -$14,733,916 $73.35 292
2022 Q3 83,680,222 $6,357,718,291 +$227,343,238 $75.98 291
2022 Q2 80,381,456 $5,588,033,518 -$44,506,350 $69.50 291
2022 Q1 81,277,607 $6,732,621,045 +$216,637,732 $82.85 293
2021 Q4 79,039,910 $5,935,576,060 +$45,870,200 $75.08 292
2021 Q3 77,530,211 $9,007,824,387 -$79,435,404 $116.17 301
2021 Q2 77,621,320 $17,214,766,292 +$574,320,737 $221.82 351
2021 Q1 75,251,763 $9,945,540,551 +$137,940,262 $132.18 315
2020 Q4 74,207,296 $12,840,473,582 +$248,693,042 $173.04 348
2020 Q3 73,245,441 $8,150,888,382 +$548,147,986 $111.31 272
2020 Q2 69,147,487 $4,099,622,932 -$81,841,604 $59.30 257
2020 Q1 70,405,458 $4,739,588,144 +$74,841,616 $67.34 260
2019 Q4 69,182,535 $5,829,865,247 +$164,443,633 $84.27 256
2019 Q3 66,719,381 $4,988,905,238 +$90,608,393 $74.78 233
2019 Q2 65,861,063 $4,162,579,908 +$194,738,922 $63.23 190
2019 Q1 63,569,972 $3,062,108,451 +$300,901,329 $48.17 195
2018 Q4 57,301,030 $1,918,395,943 +$53,781,587 $33.48 162
2018 Q3 54,688,021 $2,865,670,263 +$204,094,768 $52.40 173
2018 Q2 51,789,754 $1,621,010,556 +$259,146,142 $31.30 159
2018 Q1 44,010,189 $959,322,549 +$148,501,027 $21.80 128
2017 Q4 37,435,567 $756,203,558 +$13,057,344 $20.20 124
2017 Q3 36,815,555 $730,830,514 +$98,783,340 $19.85 103
2017 Q2 31,878,023 $551,480,454 +$204,314,280 $17.30 83
2017 Q1 20,224,271 $164,053,284 +$27,070,509 $8.10 68
2016 Q4 20,282,026 $159,204,948 +$10,262,044 $7.85 73
2016 Q3 18,826,170 $160,713,151 -$21,836,369 $8.54 62
2016 Q2 19,435,597 $226,808,591 +$67,471,069 $11.67 65
2016 Q1 13,616,633 $196,972,145 +$32,373,235 $14.48 56
2015 Q4 11,312,689 $249,219,971 +$248,824,971 $22.36 47